| Autor: |
Barisio D'Angelo MG; Facultad de Medicina, Universidad de Buenos Aires, Argentina., Mariel Actis A, Outomuro D |
| Jazyk: |
Spanish; Castilian |
| Zdroj: |
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru [Rev Gastroenterol Peru] 2009 Jan-Mar; Vol. 29 (1), pp. 44-50. |
| Abstrakt: |
Non-alcoholic fatty liver disease (NAFLD), defined as excessive fat accumulation into the hepatocytes, has a prevalence of approximately 15 to 25%. Frequently associated risk factors for NAFLD are obesity, type 2 diabetes and dyslipidemia. It has been proponed that a mitochondrial dysfunction would play a crucial role in the disease development.On the other hand, focus is on insulin resistance syndrome, the only metabolic alteration strongly associated with this malady. The disease is suspected in individuals with insulina resistance characteristics such as metabolic syndrome and also in those with augmented serum aminotransferases levels. Different tests with biochemical markers have been proposed to predict the development of fibrosis or steatohepatitis. Therapeutic options in NAFLD patients are limited and weight lost remains as the most recommended one. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
